Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency.

Journal: International journal of molecular sciences

Volume: 25

Issue: 5

Year of Publication: 2024

Affiliated Institutions:  School of Medicine, Deakin University, Geelong, VIC , Australia.

Abstract summary 

The Janus kinase (JAK) family is a small group of protein tyrosine kinases that represent a central component of intracellular signaling downstream from a myriad of cytokine receptors. The JAK3 family member performs a particularly important role in facilitating signal transduction for a key set of cytokine receptors that are essential for immune cell development and function. Mutations that impact JAK3 activity have been identified in a number of human diseases, including somatic gain-of-function (GOF) mutations associated with immune cell malignancies and germline loss-of-function (LOF) mutations associated with immunodeficiency. The structure, function and impacts of both GOF and LOF mutations of JAK3 are highly conserved, making animal models highly informative. This review details the biology of JAK3 and the impact of its perturbation in immune cell-related diseases, including relevant animal studies.

Authors & Co-authors:  Liongue Ratnayake Basheer Ward

Study Outcome 

Source Link: Visit source

Statistics
Citations :  O’Shea J.J., Holland S.M., Staudt L.M. JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 2013;368:161–170. doi: 10.1056/NEJMra1202117.
Authors :  4
Identifiers
Doi : 2977
SSN : 1422-0067
Study Population
Male,Female
Mesh Terms
Animals
Other Terms
JAK3;cytokine;cytokine receptor;immunity;immunodeficiency;leukemia
Study Design
Study Approach
Country of Study
Mali
Publication Country
Switzerland